siRNA-mediated inhibition of endogenous Huntington disease gene expression induces an aberrant configuration of the ER network in vitro

被引:36
作者
Omi, K
Hachiya, NS
Tokunaga, K
Kaneko, K [1 ]
机构
[1] Tokyo Med Univ, Dept Physiol, Tokyo 1608402, Japan
[2] Univ Tokyo, Grad Sch Med, Dept Human Genet, Tokyo 1130033, Japan
关键词
huntingtin; Huntington disease; mouse homologue of huntingtin; short interfering RNA; endoplasmic reticulum; microtubules;
D O I
10.1016/j.bbrc.2005.10.061
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Huntingtin is a ubiquitously expressed cytoplasmic protein encoded by the Huntington disease (HD) gene, in which a CAG expansion induces an autosomal dominant progressive neurodegenerative disorder; however, its biological function has not been completely elucidated. Here, we report for the first time that short interfering RNA (siRNA) -mediated inhibition of endogenous Hdh (a mouse homologue of huntingtin) gene expression induced an aberrant configuration of the endoplasmic reticulum (ER) network in vitro. Studies using inummofluorescence microscopy with several ER markers revealed that the ER network appeared to be congregated in various types of cell lines transfected with siRNA directed against Hdh, but not with other siRNAs so far tested. Other subcellular organelles and structures, including the nucleus, Golgi apparatus, mitochondria, lysosomes, microtubules, actin cytoskeletons, cytoplasm, lipid rafts, and plasma membrane, exhibited normal configurations. Western blot analysis of cellular prion protein (PrPC) revealed normal glycosylation, which is a simple marker of post-translational modification in the ER and Golgi compartments, and immunofluorescence microscopy detected no altered subcellular distribution of PrPC in the post-ER compartments. Further investigation is required to determine whether the distorted ER network, i.e., loss of the huntingtin function, participates in the development of HD. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:1229 / 1235
页数:7
相关论文
共 40 条
[1]   Fast transport and retrograde movement of huntingtin and HAP 1 in axons [J].
BlockGalarza, J ;
Chase, KO ;
Sapp, E ;
Vaughn, KT ;
Vallee, RB ;
DiFiglia, M ;
Aronin, N .
NEUROREPORT, 1997, 8 (9-10) :2247-2251
[2]  
Boado RJ, 2000, J PHARMACOL EXP THER, V295, P239
[3]   RINGS, MAPS AND MICROTUBULES [J].
BURNS, R .
NATURE, 1978, 273 (5665) :709-710
[4]   Loss of normal huntingtin function: new developments in Huntington's disease research [J].
Cattaneo, E ;
Rigamonti, D ;
Goffredo, D ;
Zuccato, C ;
Squitieri, F ;
Sipione, S .
TRENDS IN NEUROSCIENCES, 2001, 24 (03) :182-188
[5]  
CONNEALLY PM, 1984, AM J HUM GENET, V36, P506
[6]   HUNTINGTIN IS A CYTOPLASMIC PROTEIN ASSOCIATED WITH VESICLES IN HUMAN AND RAT-BRAIN NEURONS [J].
DIFIGLIA, M ;
SAPP, E ;
CHASE, K ;
SCHWARZ, C ;
MELONI, A ;
YOUNG, C ;
MARTIN, E ;
VONSATTEL, JP ;
CARRAWAY, R ;
REEVES, SA ;
BOYCE, FM ;
ARONIN, N .
NEURON, 1995, 14 (05) :1075-1081
[7]   Inactivation of Hdh in the brain and testis results in progressive neurodegeneration and sterility in mice [J].
Dragatsis, I ;
Levine, MS ;
Zeitlin, S .
NATURE GENETICS, 2000, 26 (03) :300-306
[8]   INACTIVATION OF THE MOUSE HUNTINGTONS-DISEASE GENE HOMOLOG HDH [J].
DUYAO, MP ;
AUERBACH, AB ;
RYAN, A ;
PERSICHETTI, F ;
BARNES, GT ;
MCNEIL, SM ;
GE, P ;
VONSATTEL, JP ;
GUSELLA, JF ;
JOYNER, AL ;
MACDONALD, ME .
SCIENCE, 1995, 269 (5222) :407-410
[9]   Killing the messenger: Short RNAs that silence gene expression [J].
Dykxhoorn, DM ;
Novina, CD ;
Sharp, PA .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2003, 4 (06) :457-467
[10]   Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules [J].
Gauthier, LR ;
Charrin, BC ;
Borrell-Pagès, M ;
Dompierre, JP ;
Rangone, H ;
Cordelières, FP ;
De Mey, J ;
MacDonald, ME ;
Lessmann, V ;
Humbert, S ;
Saudou, F .
CELL, 2004, 118 (01) :127-138